Cargando…
Clinical experience with non‐invasive prenatal screening for single‐gene disorders
OBJECTIVE: To assess the performance of a non‐invasive prenatal screening test (NIPT) for a panel of dominant single‐gene disorders (SGD) with a combined population incidence of 1 in 600. METHODS: Cell‐free fetal DNA isolated from maternal plasma samples accessioned from 14 April 2017 to 27 November...
Autores principales: | Mohan, P., Lemoine, J., Trotter, C., Rakova, I., Billings, P., Peacock, S., Kao, C.‐Y., Wang, Y., Xia, F., Eng, C. M., Benn, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302116/ https://www.ncbi.nlm.nih.gov/pubmed/34358384 http://dx.doi.org/10.1002/uog.23756 |
Ejemplares similares
-
Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
por: Hedriana, Herman, et al.
Publicado: (2019) -
Re: Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate
por: Jelsema, R., et al.
Publicado: (2020) -
Non-invasive prenatal screening: A 20-year experience in Italy
por: Palka, Chiara, et al.
Publicado: (2019) -
Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures
por: DiNonno, Wendy, et al.
Publicado: (2019) -
Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome
por: Gross, S. J., et al.
Publicado: (2016)